32. Faculty Research
32.6. Ongoing Review (for FDA-funded protocols and full committee reviewed protocols)
1. Investigators will be informed of the above investigator's responsibilities.
2. Approximately one year after the approval of a proposal, investigators will be sent a questionnaire concerning the research. The response will be reviewed by the Chair or, at his discretion, the Board. If there are no problems or matters of concern the Chair can re-approve the proposal for a period of one year. If research is still on-going four years after the original approval, a new application must be submitted.
3. At the time a proposal is submitted, the Board may request follow-up reports from investigators at shorter intervals than one year. The Board may also request other mechanisms of oversight for specific proposals.